Memorial Sloan Kettering Cancer Center: all 1,957 studies

Page 20 of 20. Open to participants first (323), then studies with results posted, then the rest; newest registration first within each.

• Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal CancerCompletedNCT00003360Phase 1
• T138067 Sodium in Treating Patients With Advanced Refractory CancerCompletedNCT00003359Phase 1
• Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00003358Phase 1
• Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of DiseaseCompletedNCT00003357Phase 1
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00003346Phase 2
• Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerCompletedNCT00003345Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney CancerCompletedNCT00003342Phase 1
• Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By ChemotherapyCompletedNCT00003341Phase 3
• Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00003242Phase 1
• Ifosfamide and Topotecan in Treating Patients With Refractory Solid TumorsCompletedNCT00003198Phase 1
• Green Tea Extract in Treating Patients With Advanced Solid TumorsCompletedNCT00003197Phase 1
• High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsCompletedNCT00003173Phase 2
• Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder CancerCompletedNCT00003133Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder CancerCompletedNCT00003105Phase 1/2
• Computer Planned Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00003104Phase 2
• Chemotherapy in Treating Patients With Solid TumorsCompletedNCT00003103Phase 1/2
• Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With OligodendrogliomaCompletedNCT00003101Phase 2
• Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the EsophagusCompletedNCT00003087Phase 2
• Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric CancerCompletedNCT00003055Phase 2
• Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00003037Phase 1/2
• Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic CancerCompletedNCT00003025Phase 1
• Monoclonal Antibody A1G4 Plus BCG in Treating Patients With CancerCompletedNCT00003023Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerCompletedNCT00003022Phase 1
• Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid TumorsCompletedNCT00003004Phase 1
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's LymphomaCompletedNCT00002982Phase 2
• PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by SurgeryCompletedNCT00002930Phase 2/3
• Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian CancerCompletedNCT00002928Phase 2
• Combination Chemotherapy in Treating Patients With Stage II Bladder CancerCompletedNCT00002919Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous LeukemiaCompletedNCT00002890Phase 1
• Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal CancerCompletedNCT00002828Phase 1
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal CancerCompletedNCT00002801Phase 1
• Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002800Phase 2
• Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach CancerCompletedNCT00002783Phase 2
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's LymphomaCompletedNCT00002738Phase 2
• T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic AnemiaCompletedNCT00002718Phase 2
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the EsophagusCompletedNCT00002711Phase 1
• Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00002697Phase 2
• Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's LymphomaCompletedNCT00002691Phase 2
• Combination Chemotherapy in Patients With Advanced Urinary Tract CancerCompletedNCT00002684Phase 2
• Chemotherapy in Treating Patients With RetinoblastomaCompletedNCT00002675Phase 2
• Biological Therapy in Treating Patients With Prostate CancerCompletedNCT00002637Phase 1/2
• Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With NeuroblastomaCompletedNCT00002634Phase 2
• Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in RemissionCompletedNCT00002609Phase 2
• Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002598Phase 2
• Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell TumorsCompletedNCT00002596Phase 3
• High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in RemissionCompletedNCT00002567Phase 2
• Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced NeuroblastomaCompletedNCT00002560Phase 2
• Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous CisplatinCompletedNCT00002559Phase 1/2
• Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second RemissionCompletedNCT00002534Phase 3
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare CancerCompletedNCT00002515Phase 2
• Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeCompletedNCT00002502Phase 2
• Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell TumorsCompletedNCT00002489Phase 2
• Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung CancerCompletedNCT00002484Phase 1
• Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00002480Phase 1
• Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's LymphomaCompletedNCT00002471Phase 2
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone CancerCompletedNCT00002466Phase 2
• Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second RemissionCompletedNCT00002458Phase 2

← Memorial Sloan Kettering Cancer Center overview and focus areas